World

Iran warns of 'severe' response in wake of Trump's threat

Dec 31, 2025

Tehran [Iran], December 31: Iran has promised to respond harshly to any aggression after United States President Donald Trump threatened further military action, should Tehran attempt to rebuild its nuclear programme or missile capabilities.
President Masoud Pezeshkian issued the warning on X on Tuesday, a day after Trump met Prime Minister Benjamin Netanyahu at his Florida estate, where he firmly leaned into the Israeli regional narrative yet again. The US had not previously said it would target Iran's missile capabilities, which has long been an Israeli aspiration, focusing instead on Tehran's nuclear programme.
The leaders' comments raise the spectre of renewed conflict just months after a devastating 12-day war in June that killed more than 1,100 Iranians and left 28 in Israel dead. Pezeshkian said the response of Iran to any aggression would be "severe and regret-inducing". His defiant message came hours after Trump told reporters at his Mar-a-Lago resort that Washington could carry out another major assault on Iran. (Agencies)
Source: Qatar Tribune

More news

Sirolimus-Coated Balloon Matches Drug-Eluting Stent at One Year in Large International TRANSFORM II Trial

Tampa (Florida) [US], November 2: Sirolimus-coated balloon (SCB) strategy was non-inferior to contemporary everolimus-eluting stents (EES) for Target Lesion Failure (TLF) at 12 months in patients with de novo coronary artery disease. These are the results of the TRANSFORM II randomised trial, presented today as a Late-Breaking Clinical Trial at TCT 2026 and accepted in The Lancet which confirm how MagicTouch Sirolimus Coated Balloon (Concept Medical) matches contemporary best in class stent. Late-breaking results presented at TCT 2026 show an implant-free strategy with MagicTouch Sirolimus Coated Balloon is non-inferior to everolimus-eluting in de novo coronary artery disease.

Nov 02, 2026